{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T20:10:45Z","timestamp":1794427845519,"version":"4.9.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-68661-4","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T12:46:51Z","timestamp":1768999611000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["SAMSN1 restrains NK cell mediated anti-tumor immunity in hepatocellular carcinoma"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-1037-127X","authenticated-orcid":false,"given":"Ruifeng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huidi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojing","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianli","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4578-3817","authenticated-orcid":false,"given":"Jiabei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Nashan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8799-7426","authenticated-orcid":false,"given":"Cheng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"68661_CR1","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.mayocp.2023.08.017","volume":"98","author":"DZ Carvalho","year":"2023","unstructured":"Carvalho, D. Z. & St Louis, E. K. Sleepwalking Into a risky path: expanding the concerns for parasomnias in the elderly. Mayo Clin. Proc. 98, 1436\u20131438 (2023).","journal-title":"Mayo Clin. Proc."},{"key":"68661_CR2","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1007\/s10620-019-05537-2","volume":"64","author":"M Sayiner","year":"2019","unstructured":"Sayiner, M., Golabi, P. & Younossi, Z. M. Disease burden of hepatocellular carcinoma: a global perspective. Dig. Dis. Sci. 64, 910\u2013917 (2019).","journal-title":"Dig. Dis. Sci."},{"key":"68661_CR3","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41580-019-0133-3","volume":"20","author":"R Rosenzweig","year":"2019","unstructured":"Rosenzweig, R., Nillegoda, N. B., Mayer, M. P. & Bukau, B. The Hsp70 chaperone network. Nat. Rev. Mol. Cell Biol. 20, 665\u2013680 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"68661_CR4","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1053\/j.gastro.2018.08.065","volume":"156","author":"L Kulik","year":"2019","unstructured":"Kulik, L. & El-Serag, H. B. Epidemiology and management of hepatocellular carcinoma. Gastroenterology 156, 477\u2013491 e471 (2019).","journal-title":"Gastroenterology"},{"key":"68661_CR5","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMra1713263","volume":"380","author":"A Villanueva","year":"2019","unstructured":"Villanueva, A. Hepatocellular carcinoma. N. Engl. J. Med. 380, 1450\u20131462 (2019).","journal-title":"N. Engl. J. Med."},{"key":"68661_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet, J. M. et al. Hepatocellular carcinoma. Nat. Rev. Dis. Prim. 7, 6 (2021).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"68661_CR7","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","volume":"391","author":"A Forner","year":"2018","unstructured":"Forner, A., Reig, M. & Bruix, J. Hepatocellular carcinoma. Lancet 391, 1301\u20131314 (2018).","journal-title":"Lancet"},{"key":"68661_CR8","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","volume":"76","author":"M Reig","year":"2022","unstructured":"Reig, M. et al. BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update. J. Hepatol. 76, 681\u2013693 (2022).","journal-title":"J. Hepatol."},{"key":"68661_CR9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1126\/science.aaa8172","volume":"348","author":"P Sharma","year":"2015","unstructured":"Sharma, P. & Allison, J. P. The future of immune checkpoint therapy. Science 348, 56\u201361 (2015).","journal-title":"Science"},{"key":"68661_CR10","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1126\/science.aar4060","volume":"359","author":"A Ribas","year":"2018","unstructured":"Ribas, A. & Wolchok, J. D. Cancer immunotherapy using checkpoint blockade. Science 359, 1350\u20131355 (2018).","journal-title":"Science"},{"key":"68661_CR11","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1158\/0008-5472.CAN-14-3041","volume":"75","author":"A Lo","year":"2015","unstructured":"Lo, A. et al. Tumor-promoting desmoplasia is disrupted by depleting FAP-expressing stromal cells. Cancer Res. 75, 2800\u20132810 (2015).","journal-title":"Cancer Res."},{"key":"68661_CR12","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","volume":"382","author":"RS Finn","year":"2020","unstructured":"Finn, R. S. et al. Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. N. Engl. J. Med. 382, 1894\u20131905 (2020).","journal-title":"N. Engl. J. Med."},{"key":"68661_CR13","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.jhep.2021.11.030","volume":"76","author":"AL Cheng","year":"2022","unstructured":"Cheng, A. L. et al. Updated efficacy and safety data from IMbrave150: atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma. J. Hepatol. 76, 862\u2013873 (2022).","journal-title":"J. Hepatol."},{"key":"68661_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.5758\/vsi.210020","volume":"37","author":"HM Kwok","year":"2021","unstructured":"Kwok, H. M. et al. Gallium-67 scan with single photon emission computed tomography for the evaluation and monitoring of infected abdominal aortic aneurysms: a 10-year case series. Vasc. Specialist Int 37, 17 (2021).","journal-title":"Vasc. Specialist Int"},{"key":"68661_CR15","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41574-021-00482-5","volume":"17","author":"A Karlas","year":"2021","unstructured":"Karlas, A., Pleitez, M. A., Aguirre, J. & Ntziachristos, V. Optoacoustic imaging in endocrinology and metabolism. Nat. Rev. Endocrinol. 17, 323\u2013335 (2021).","journal-title":"Nat. Rev. Endocrinol."},{"key":"68661_CR16","doi-asserted-by":"publisher","first-page":"e407","DOI":"10.1016\/S1470-2045(23)00385-6","volume":"24","author":"EM Garton","year":"2023","unstructured":"Garton, E. M. et al. Global oncology research and training at US National Cancer Institute-designated cancer centres: results of the 2021 Global Oncology Survey. Lancet Oncol. 24, e407\u2013e414 (2023).","journal-title":"Lancet Oncol."},{"key":"68661_CR17","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/ni1582","volume":"9","author":"E Vivier","year":"2008","unstructured":"Vivier, E., Tomasello, E., Baratin, M., Walzer, T. & Ugolini, S. Functions of natural killer cells. Nat. Immunol. 9, 503\u2013510 (2008).","journal-title":"Nat. Immunol."},{"key":"68661_CR18","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1182\/blood-2007-09-077438","volume":"112","author":"MA Caligiuri","year":"2008","unstructured":"Caligiuri, M. A. Human natural killer cells. Blood 112, 461\u2013469 (2008).","journal-title":"Blood"},{"key":"68661_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.665197","volume":"12","author":"Z Jiang","year":"2021","unstructured":"Jiang, Z. et al. A 10-day-old murine model of coxsackievirus A6 infection for the evaluation of vaccines and antiviral drugs. Front. Immunol. 12, 665197 (2021).","journal-title":"Front. Immunol."},{"key":"68661_CR20","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1556\/MOnkol.52.2008.3.2","volume":"52","author":"B Dome","year":"2008","unstructured":"Dome, B. & Magyar, M. Tumor vasculature as a therapeutic target in non-small cell lung cancer. Magy. Onkol. 52, 247\u2013259 (2008).","journal-title":"Magy. Onkol."},{"key":"68661_CR21","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1084\/jem.20110698","volume":"209","author":"E Colombo","year":"2012","unstructured":"Colombo, E. et al. Stimulation of the neurotrophin receptor TrkB on astrocytes drives nitric oxide production and neurodegeneration. J. Exp. Med. 209, 521\u2013535 (2012).","journal-title":"J. Exp. Med."},{"key":"68661_CR22","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00411-020-00842-1","volume":"59","author":"U Schneider","year":"2020","unstructured":"Schneider, U., Vasi, F., Schmidli, K. & Besserer, J. A model of radiation action based on nanodosimetry and the application to ultra-soft X-rays. Radiat. Environ. Biophys. 59, 439\u2013450 (2020).","journal-title":"Radiat. Environ. Biophys."},{"key":"68661_CR23","doi-asserted-by":"publisher","first-page":"985","DOI":"10.3389\/fimmu.2018.00985","volume":"9","author":"NE McCarthy","year":"2018","unstructured":"McCarthy, N. E. & Eberl, M. Human gammadelta T-cell control of mucosal immunity and inflammation. Front. Immunol. 9, 985 (2018).","journal-title":"Front. Immunol."},{"key":"68661_CR24","doi-asserted-by":"publisher","first-page":"5373","DOI":"10.1038\/sj.onc.1204698","volume":"20","author":"JO Claudio","year":"2001","unstructured":"Claudio, J. O. et al. HACS1 encodes a novel SH3-SAM adaptor protein differentially expressed in normal and malignant hematopoietic cells. Oncogene 20, 5373\u20135377 (2001).","journal-title":"Oncogene"},{"key":"68661_CR25","doi-asserted-by":"publisher","first-page":"6273","DOI":"10.1038\/sj.onc.1204770","volume":"20","author":"P Wonerow","year":"2001","unstructured":"Wonerow, P. & Watson, S. P. The transmembrane adapter LAT plays a central role in immune receptor signalling. Oncogene 20, 6273\u20136283 (2001).","journal-title":"Oncogene"},{"key":"68661_CR26","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1126\/science.1083653","volume":"300","author":"T Pawson","year":"2003","unstructured":"Pawson, T. & Nash, P. Assembly of cell regulatory systems through protein interaction domains. Science 300, 445\u2013452 (2003).","journal-title":"Science"},{"key":"68661_CR27","doi-asserted-by":"publisher","first-page":"4370","DOI":"10.1111\/j.1742-4658.2010.07866.x","volume":"277","author":"JS Logue","year":"2010","unstructured":"Logue, J. S. & Scott, J. D. Organizing signal transduction through A-kinase anchoring proteins (AKAPs). FEBS J. 277, 4370\u20134375 (2010).","journal-title":"FEBS J."},{"key":"68661_CR28","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s42003-020-01397-z","volume":"3","author":"JJ Kwan","year":"2020","unstructured":"Kwan, J. J. et al. HACS1 signaling adaptor protein recognizes a motif in the paired immunoglobulin receptor B cytoplasmic domain. Commun. Biol. 3, 672 (2020).","journal-title":"Commun. Biol."},{"key":"68661_CR29","doi-asserted-by":"publisher","first-page":"3988","DOI":"10.4049\/jimmunol.1101598","volume":"188","author":"J Fioravanti","year":"2012","unstructured":"Fioravanti, J. et al. The fusion protein of IFN-alpha and apolipoprotein A-I crosses the blood-brain barrier by a saturable transport mechanism. J. Immunol. 188, 3988\u20133992 (2012).","journal-title":"J. Immunol."},{"key":"68661_CR30","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1097\/CM9.0000000000003606","volume":"138","author":"Y Li","year":"2025","unstructured":"Li, Y. et al. SAMSN1 causes sepsis immunosuppression by inducing macrophages to express coinhibitory molecules that cause T-cell exhaustion via KEAP1-NRF2 signaling. Chin. Med. J. 138, 1607\u20131620 (2025).","journal-title":"Chin. Med. J."},{"key":"68661_CR31","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.neo.2014.07.002","volume":"16","author":"JE Noll","year":"2014","unstructured":"Noll, J. E. et al. SAMSN1 is a tumor suppressor gene in multiple myeloma. Neoplasia 16, 572\u2013585 (2014).","journal-title":"Neoplasia"},{"key":"68661_CR32","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1096\/fba.2020-00027","volume":"2","author":"NL Friend","year":"2020","unstructured":"Friend, N. L. et al. Characterization of the role of Samsn1 loss in multiple myeloma development. FASEB Bioadv. 2, 554\u2013572 (2020).","journal-title":"FASEB Bioadv."},{"key":"68661_CR33","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.cell.2020.11.041","volume":"184","author":"Y Sun","year":"2021","unstructured":"Sun, Y. et al. Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma. Cell 184, 404\u2013421 e416 (2021).","journal-title":"Cell"},{"key":"68661_CR34","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/cmi.2016.3","volume":"13","author":"MW Robinson","year":"2016","unstructured":"Robinson, M. W., Harmon, C. & O\u2019Farrelly, C. Liver immunology and its role in inflammation and homeostasis. Cell Mol. Immunol. 13, 267\u2013276 (2016).","journal-title":"Cell Mol. Immunol."},{"key":"68661_CR35","first-page":"63","volume":"31","author":"H Zhang","year":"2024","unstructured":"Zhang, H., Yang, L., Wang, T. & Li, Z. NK cell-based tumor immunotherapy. Bioact. Mater. 31, 63\u201386 (2024).","journal-title":"Bioact. Mater."},{"key":"68661_CR36","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.3390\/biomedicines11041020","volume":"11","author":"F Pelizzaro","year":"2023","unstructured":"Pelizzaro, F., Farinati, F. & Trevisani, F. Immune checkpoint inhibitors in hepatocellular carcinoma: current strategies and biomarkers predicting response and\/or resistance. Biomedicines 11, 1020 (2023).","journal-title":"Biomedicines"},{"key":"68661_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.652172","volume":"12","author":"R Mohr","year":"2021","unstructured":"Mohr, R. et al. Lessons from immune checkpoint inhibitor trials in hepatocellular carcinoma. Front. Immunol. 12, 652172 (2021).","journal-title":"Front. Immunol."},{"key":"68661_CR38","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.ccell.2024.05.006","volume":"42","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. Tumor cells impair immunological synapse formation via central nervous system-enriched metabolite. Cancer Cell 42, 985\u20131002 e1018 (2024).","journal-title":"Cancer Cell"},{"key":"68661_CR39","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/s41592-020-0905-x","volume":"17","author":"B Li","year":"2020","unstructured":"Li, B. et al. Cumulus provides cloud-based data analysis for large-scale single-cell and single-nucleus RNA-seq. Nat. Methods 17, 793\u2013798 (2020).","journal-title":"Nat. Methods"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68661-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68661-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68661-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T14:56:10Z","timestamp":1771599370000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68661-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["68661"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-68661-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"17 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1903"}}